Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001079973-12-000505
Filing Date
2012-07-03
Accepted
2012-07-03 13:16:05
Documents
1
Period of Report
2012-06-29

Document Format Files

Seq Description Document Type Size
1 appy_merson.html 4  
1 appy_merson.xml 4 3298
  Complete submission text file 0001079973-12-000505.txt   4692
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Issuer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 6308 NORTH CHARLES STREET BALTIMORE MD 21212
Business Address
Merson Michael R (Reporting) CIK: 0001440213 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33675 | Film No.: 12943434